PharmaNutra participates in the second edition of Mediobanca’s Italian Mid Cap Conference
The Group’s senior management presented its results and new development prospects to the financial community, which met for the Italian Mid Cap Conference at Mediobanca’s headquarters in Milan.
PharmaNutra S.p.A. took part today in the “2nd Italian Mid Cap Conference” organised by Mediobanca S.p.A. – recently appointed Group Specialist – at its headquarters in Milan.
PharmaNutra, which was present with its President, Andrea Lacorte, Vice President Roberto Lacorte, COO Carlo Volpi and CFO Francesco Sarti, met with investors, with the aim of presenting the results achieved since its listing on AIM Italia, dated July 2017, illustrating the company’s future prospects.
The excellent performance of the Company is highlighted by both the latest studies published by financial analysts at Alantra and CFO SIM, which, according to recent market data sourced from IQVIA, officialised by FederSalus at the end of the year, according to which SiderAL® Forte 20 capsules – one of the flagship products of the PharmaNutra line based on Sucrosomial Iron® – results as follows the best-selling nutritional supplement in Italy.
“We are proud to have participated in Mediobanca’s Italian Mid Cap Conference together with other Italian companies of excellence”, commented Roberto Lacorte, Vice President of PharmaNutra. “Today, we have perceived a major sign of change: not only on the entrepreneurial level, given the extremely positive and solid growth figures presented by the Group, but also in terms of financial relations. Thanks to the close collaboration with Mediobanca, we had the honour of sharing this ambitious development path with some of the largest investors in the financial community. I am convinced that this constant dialogue with stakeholders is essential to support and strengthen PharmaNutra’s growth in the medium to long term”.